AHA: Statin Side Effects Rare, Benefits Outweigh Risks

The benefits of statin medications outweigh their risks, the American Heart Association says, responding to a study that came out last week that argued the cholesterol-lowering drugs are overprescribed.

The AHA said that about 10% of Americans on a statin stop taking it because of side effects that they believe are caused by the drug, but may not be. If you think you are experiencing side effects from a statin, you should not stop taking it, Mark Creager, MD, director of the Heart and Vascular Center at Dartmouth-Hitchcock Medical Center, said in a statement. Instead, talk to your doctor. Creager noted that stopping a statin can significantly increase the risk of a heart attack or stroke.

However, if your urine suddenly turns dark, you should stop taking a statin immediately as this can be a sign of a rare condition called rhabdomyolysis. However, the AHA said, based on a review of research, this was observed in less than 0.1% of people on a statin.

One common side effect reported with statins is muscle aches or pain. The AHA said based on their analysis of studies, “no more than 1% of patients develop muscle symptoms that are likely caused by statin drugs.” The group also said that muscle aches and pain can have many causes, such as low vitamin D levels, and are common in middle-aged and older adults.

The AHA also said that some complaints of muscle pain while on a statin are a result of the so-called “nocebo effect.” This is the idea that if a person is told of the potential side effects of a medicine, they are more likely to experience them. The AHA argued that reports in the media of statins causing muscle pain, doctors warning about muscle aches and drug package inserts advising of the possibility support this idea.

The AHA analysis found that statins may slightly raise the risk for diabetes, but in those who already have risk factors for it, such as obesity. In addition, there was no evidence of a relationship between statins and conditions such as cancer, cataracts, cognitive dysfunction, peripheral neuropathy, erectile dysfunction and tendonitis.


Jonathan Block

Jonathan Block

Jonathan Block is an associate editor at BioCentury, which provides news and information about the biotechnology and pharmaceutical industries. Prior to joining BioCentury in 2019, Jonathan worked for MedShadow as content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?


Latest News

Diabetes, Fertility Supplements, Nootropics

Diabetes, Fertility Supplements, Nootropics

Supplements are sold without review or approval of the FDA. They are not allowed to make specific health claims, but general ones, such as “improves well-being” and “boosts energy” are legal.  That leaves the door open for unscrupulous, or careless, manufacturers. The FDA also does not regulate the manufacturers recommended…

Vitamin E, the Source of Mystery Vaping Illness

Vitamin E, the Source of Mystery Vaping Illness

A “breakthrough” in the investigation of vaping illness and death, EVALI, has been announced by Federal health officials and the CDC (Centers for Disease Control).

  • Advertisement